Results 61 to 70 of about 200 (95)

Advancing early access policies for innovative cancer drugs: a scoping review and explorative analysis in the Italian setting. [PDF]

J Pharm Policy Pract
d'Errico M, Giannarelli D, d'Angela D, Pinto C, Polistena B, Spandonaro F.   +5 more
europepmc   +1 more source

A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature. [PDF]

Patient
Shaw C, Longworth L, Bennett B, McEntee-Richardson L, Shaw JW.   +4 more
europepmc   +1 more source

Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice. [PDF]

Front Pharmacol
Delemarre L, Huys I, Van Dyck W, Simoens S.   +3 more
europepmc   +1 more source

Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France. [PDF]

Digit Health
Arcà E, Heldt D, Smith M.
europepmc   +1 more source

Paving the road for a successful EU HTA Reform implementation. [PDF]

Glob Reg Health Technol Assess
Severens H, Dillon A, Meyer F, Jommi C, Iga L, Canonico PL, Solà-Morales O, Altman H.   +7 more
europepmc   +1 more source

Women's Insights on Extended Adjuvant Endocrine Therapy for Breast Cancer: Qualitative Online Forums Study. [PDF]

J Med Internet Res
Cazorla G, Seguin L, Provansal M, De Montgolfier S, Mancini J.   +4 more
europepmc   +1 more source

Clinical Decision Support Systems and Artificial Intelligence in ADHD Assessment and Rehabilitation: Opportunities and Challenges for Technology-Assisted Care. [PDF]

Healthcare (Basel)
Dahò M, Caci B.
europepmc   +1 more source

Patient organizations involvement in healthcare: a rapid review and conceptual framework. [PDF]

Global Health
Gentilini A, Parvanova I, Ghazi S, Scarfone KM, Kohler J.   +4 more
europepmc   +1 more source

Digital health reimbursement: A scoping review of global lessons and policy implications. [PDF]

Digit Health
Rabiei R, Almasi S.
europepmc   +1 more source